A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL. Takizawa J, Yoshida I, Ogawa Y, Toubai T, et al. Int J Hematol 2026;123:375-384.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takizawa J, Yoshida I, Ogawa Y, Toubai T, et al. A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL. Int J Hematol 2026;123:375-384.
PMID: 41313523